NCT06114784 Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
| NCT ID | NCT06114784 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Zhejiang University |
| Condition | Severe Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-09-25 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-09-25 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was a prospective multicenter cohort of severe pneumonia. And by collecting clinical samples to clarify the correlation between lung microbiome, intestinal microbiome, host susceptibility, and prognosis of severe pneumonia patients.
Eligibility Criteria
Inclusion Criteria: 1\. New lung infection that meets one of the following definitions: the patient receives mechanical ventilation (invasive or non-invasive) due to acute respiratory failure, with a PEEP level of 5cm or above; Patients receiving high flow oxygen therapy with a FiO2 of 50% or more and a PaO2: FiO2 ratio below 300 Exclusion Criteria: 1. Expected length of stay in ICU is less than 1 day 2. Pregnant
Contact & Investigator
Lingtong Huang, M.D.
PRINCIPAL INVESTIGATOR
First Affiliated Hospital of Zhejiang University
Frequently Asked Questions
Who can join the NCT06114784 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Severe Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06114784 currently recruiting?
Yes, NCT06114784 is actively recruiting participants. Contact the research team at lingtonghuang@zju.edu.cn for enrollment information.
Where is the NCT06114784 trial being conducted?
This trial is being conducted at Hangzhou, China, Hangzhou, China, Hangzhou, China, Hangzhou, China and 11 additional locations.
Who is sponsoring the NCT06114784 clinical trial?
NCT06114784 is sponsored by First Affiliated Hospital of Zhejiang University. The principal investigator is Lingtong Huang, M.D. at First Affiliated Hospital of Zhejiang University. The trial plans to enroll 2,000 participants.